drugset / Trial / NCT07354477
Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation
NaSequentialOpen-labelTreatment
Summary
Pilot, single-site, prospective study of QLS-111 0.015 % in subjects with NPDR, OAG or NTG
Timeline
- Start
- 2026-02-20
- Primary completion
- 2026-09
- Completion
- 2026-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QLS-111 | Unknown | 0.015 % | — |
| Subject | QLS-111 | Unknown | 0.075 % | — |